Fabtech Cleanrooms Limited
BSE: FABCLEAN · Industrial Products
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Fabtech Cleanrooms Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Fabtech Technologies International Limited provides turnkey engineering and construction solutions for the pharmaceutical, biotechnology, and healthcare sectors. The company specialises in the design and commissioning of modular cleanrooms, containment systems, and specialised process equipment that meet international regulatory standards.
Business Model
The company operates as an integrated infrastructure provider, generating revenue through the design, engineering, and manufacturing of high-grade cleanroom partitions, air handling units, and pharmaceutical machinery. It serves a global client base by delivering compliant, end-to-end manufacturing facilities.
Management Commentary
Management is focused on leveraging the recent stock exchange listing to finance strategic expansion and research initiatives. The company aims to strengthen its position as a key infrastructure provider for life sciences manufacturing.
Growth Outlook
Growth is driven by the increasing demand for high-standard pharmaceutical manufacturing infrastructure across Asia, Africa, and the Middle East. The company is prioritising research and development to enhance its specialised process equipment offerings.
Key Risks
- Regulatory Compliance Risk. Failure to maintain strict adherence to international standards like USFDA and PICS could lead to project rejection and reputational damage.
- Geopolitical Instability. Operating across diverse regions such as Africa and the Middle East exposes the company to risks associated with political volatility and currency fluctuations.
- Project Execution Risk. As a turnkey provider, the company faces risks related to cost overruns, supply chain disruptions, and delays in large-scale engineering projects.
- Sector Cyclicality. The company's performance is heavily dependent on capital expenditure cycles within the pharmaceutical and biotechnology industries.
Start your research today
Unlock AI insights, financials, peers and live data on Fabtech Cleanrooms Limited and 5,000+ companies — free.
Peers · Industrial Products
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Fabtech Cleanrooms LimitedFABCLEAN | ₹674 Cr | — | — | — | 10.0% | — | — | +32.5% |
Bajaj Steel Industries LimitedBAJAJST | ₹728 Cr | 23.41 | 11.18 | -2.6% | 12.1% | 7.2% | 10.6% | -40.8% |
Axtel IndustriesAXTEL | ₹728 Cr | 22.54 | 15.11 | 42.1% | 20.6% | 25.3% | 32.8% | -8.1% |
Indef Manufacturing LimitedBAJAJINDEF | ₹710 Cr | 28.45 | 23.31 | — | 14.9% | 8.6% | 8.3% | -41.4% |
Integra Engineering India Ltd.INTEGRAEN | ₹621 Cr | 41.72 | 23.10 | -5.1% | 16.6% | 14.4% | 21.1% | -24.3% |
ArtsonARTSON | ₹619 Cr | 33.14 | 20.50 | 8.7% | 22.6% | 686.8% | 128.0% | -24.1% |
As of Mar 2026
Financials
Fabtech Cleanrooms Limited
BSE: FABCLEAN · Industrial Products
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Fabtech Cleanrooms Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Fabtech Technologies International Limited provides turnkey engineering and construction solutions for the pharmaceutical, biotechnology, and healthcare sectors. The company specialises in the design and commissioning of modular cleanrooms, containment systems, and specialised process equipment that meet international regulatory standards.
Business Model
The company operates as an integrated infrastructure provider, generating revenue through the design, engineering, and manufacturing of high-grade cleanroom partitions, air handling units, and pharmaceutical machinery. It serves a global client base by delivering compliant, end-to-end manufacturing facilities.
Management Commentary
Management is focused on leveraging the recent stock exchange listing to finance strategic expansion and research initiatives. The company aims to strengthen its position as a key infrastructure provider for life sciences manufacturing.
Growth Outlook
Growth is driven by the increasing demand for high-standard pharmaceutical manufacturing infrastructure across Asia, Africa, and the Middle East. The company is prioritising research and development to enhance its specialised process equipment offerings.
Key Risks
- Regulatory Compliance Risk. Failure to maintain strict adherence to international standards like USFDA and PICS could lead to project rejection and reputational damage.
- Geopolitical Instability. Operating across diverse regions such as Africa and the Middle East exposes the company to risks associated with political volatility and currency fluctuations.
- Project Execution Risk. As a turnkey provider, the company faces risks related to cost overruns, supply chain disruptions, and delays in large-scale engineering projects.
- Sector Cyclicality. The company's performance is heavily dependent on capital expenditure cycles within the pharmaceutical and biotechnology industries.
Start your research today
Unlock AI insights, financials, peers and live data on Fabtech Cleanrooms Limited and 5,000+ companies — free.
Peers · Industrial Products
As of Mar 2026